Artificial-Intelligence-based Early Detection of Diabetic Retinopathy (FUNDUS AI)
- Sponsor
- University Hospital Tuebingen
- Study ID
- NCT07378891
- Status
- Enrolling By Invitation
Conditions
- Diabetes (DM)
- Prediabetes
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Study Details
Examination of individuals with prediabetes and established diabetes for early signs of diabetic retinopathy.
Key Dates
- First listed
- Jan 30, 2026
- Start date
- Dec 1, 2025
- Status verified
- Jan 2026
- Primary completion
- Oct 1, 2028
- Completion
- Dec 15, 2028
Study Design
- Enrollment
- 100 participants (estimated)
Arms
- Arm: Prediabetes and DiabetesParticipants with prediabetes and diabetes
Primary Outcome Measure
Assessment of retinal changes [ Time Frame: Day 1 ]
Related Studies
- Blood Markers of Early Pancreas CancerRecruiting · University of Nebraska · Omaha, Nebraska
- Bromocriptine for Patients With Schizophrenia and PrediabetesPHASE4 · Not Yet Recruiting · VA Pittsburgh Healthcare System · Pittsburgh, Pennsylvania
- Glucose Variability and Cognition in PrediabetesRecruiting · University of Maryland, Baltimore · Baltimore, Maryland
- Mechanisms for Activation of Beige Adipose Tissue in HumansPHASE2 · Recruiting · Philip Kern · Lexington, Kentucky